Zoekresultaten - "Continuous erythropoietin receptor activator"

Cost-effectiveness of continuous erythropoietin receptor activator in anemia door Schmid H

Connect to this object online.

Cutaneous leukocytoclastic vasculitis induced by continuous erythropoietin receptor activator door Hyeok-Jin Kwon, MD, Jung-Hwan Kim, MD, Dong-Wha Yoo, MD, Tae-Hoon Kim, MD, Jung-Ho Yoon, MD, Ki-Ho Kim, MD, PhD

Connect to this object online.

Potential effective treatment of shortening continuous erythropoietin receptor activator treatment interval combined with iron supplementation in hemodialysis patients door Yuki Kawai, Yoshiyuki Toya, Hiromichi Wakui, Tetsuya Fujikawa, Eiko Ueda, Kengo Azushima, Sho Kinguchi, Hiroshi Mitsuhashi, Tomoyuki Kawano, Tadashi Kuji, Satoshi Yamaguchi, Toshimasa Ohnishi, Kouichi Tamura

Connect to this object online.

Efficacy and cost-effectiveness of darbepoetin alfa once every 4 weeks versus continuous erythropoietin receptor activator once every 4 weeks for anemia correction in patients with chronic kidney disease not on dialysis door Geo Neul Park, Kyung Ho Lee, Ji Eun Moon, Soo Jeong Choi, Moo Yong Park, Jin Kuk Kim, Byung Chul Yu

Connect to this object online.

Effects of Erythropoietin-Stimulating Agents on Blood Pressure in Patients with Non-Dialysis CKD and Renal Anemia door Kohji Ohki, Hiromichi Wakui, Kazushi Uneda, Kengo Azushima, Kotaro Haruhara, Sho Kinguchi, Shingo Urate, Takayuki Yamada, Takahiro Yamaji, Ryu Kobayashi, Tomohiko Kanaoka, Shintaro Minegishi, Tomoaki Ishigami, Tetsuya Fujikawa, Yoshiyuki Toya, Kouichi Tamura

Connect to this object online.